Docs look to Wikipedia for condition info: Manhattan Research

Share this article:

Nearly 50% of US physicians going online for professional purposes are visiting Wikipedia for health and medical information, especially condition information, according to a Manhattan Research study. 

Despite using the online encyclopedia as a resource for information, only about 10% of the 1,900 physicians surveyed created new posts or edited existing posts on Wikipedia, the study found.

“The number of physicians turning to Wikipedia for medical information has doubled in the past year alone, said Meredith Abreu Ressi, vice president of research at Manhattan Research. “Physicians, just like consumers, are heavily search engine reliant, and often Wikipedia results are what come up in the top of the organic results.”

Abreu Ressi noted the concern about accuracy regarding Wikipedia, which allows its users to create content for the site essentially without restriction. Articles are subject to perpetual editing by Wikipedia's readers. Inevitably, false information sometimes slips through the cracks. “We've seen medical wikis such as WiserWiki and AskDrWiki appear over the past few years to try to address this issue, but to date, these types of wikis are not seeing as much physician traffic as Wikipedia,” said Abreu Ressi.

The Manhattan Research study, titled Taking the Pulse, surveyed practicing physicians online and by random digital dial telephone interview during the first quarter of 2009.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...